Luminex Corp

Austin, TX Part of Diasorin Inc.

UEI
VLLHHV5E3AL1
CAGE
1K8M4
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Active through

Company facts

FY2025 rankings

Its parent company, Diasorin S.P.A., ranks:

and 2 more

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
12212 Technology Blvd, Austin, TX 78727, USA
Website
diasorin.com
Founded
2000
Employees
1K-5K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date -$13,270
FY2026 $1,396,763
FY2025 $2,553,269
FY2024 $636,015
FY2023 $2,194,211

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Defense Logistics Agency $508,321
2 Defense Health Agency $300,876
3 Department of Veterans Affairs $249,502
4 Department of Agriculture $142,462
5 Department of the Navy $89,020
6 Department of Health and Human Services $67,576
7 Environmental Protection Agency $25,736

Contract vehicles

Expired vehicles (2)

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Contract subawards

Prime contractor Prime award Amount Awarded
Battelle National Biodefense Institute, LLC IGF::CT::IGF HSHQDC15C00064 $39,848

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
National Foundation For The Centers For Disease Control & Prevention, Inc. Partnerships to Strengthen Health Security and Respond to Health Threats ARP NU2HGH000097 $90,459

Similar vendors

About the company

Luminex Corp, a foreign-owned manufacturer of multiplex diagnostic platforms and reagents, operates as a prime contractor delivering in vitro diagnostic equipment, assay kits, reagents, and maintenance services to the federal government across full-and-open competition, with no predominant set-aside posture. The company is a subsidiary of Diasorin Inc. and competes across Defense, Veterans Affairs, CDC, and civilian health agencies without SBA certifications.

Luminex's federal footprint centers on specialized diagnostic reagents, microspheres, calibration and performance verification kits, and preventative maintenance plans for its MAGPIX, INTELLIFLEX, and related multiplex analyzer platforms. Representative contracts include a $5.762 million single-award Blanket Purchase Agreement with the Department of the Air Force's 711th Human Performance Wing for Luminex reagents extending through January 31, 2030; a $250,000 Indefinite Delivery Contract with USDA Veterinary Services for Salmonella serotyping assay kits through December 31, 2026; and a $519,140 Blanket Purchase Agreement with the Department of Veterans Affairs for PCR testing services at the VA Pittsburgh Healthcare System through June 30, 2028. Delivery orders against these vehicles have included a $302.6 million order from the Defense Logistics Agency Medical Supply Chain for XTAG Cystic Fibrosis Kits, an $80.2 million purchase order from the Bureau of Medicine and Surgery for the NxTAG Respiratory Panel, and a $76.7 million procurement from the Naval Health Research Center for NxTAG Respiratory Pathogen Panel reagents and MAGPIX components.

Customer concentration is extreme and narrow. The Defense Logistics Agency Troop Support Medical Supply Chain dominates the portfolio at 339 awards totaling $52 million in combined potential value—roughly 31% of all awards and 32% of total potential value. The Department of the Navy Bureau of Medicine and Surgery follows at 83 awards and $16.3 million, and the Department of the Air Force Materiel Command at Wright-Patterson Air Force Base contributes 23 awards for $15.9 million. Together, these three customers account for over half of Luminex's federal dollar volume. The CDC Pittsburgh and CDC Office of Acquisition Services rank fourth and fifth in award count but represent smaller dollars. Luminex serves 89 distinct customer agencies; however, the top five customers account for 57% of combined potential value, indicating substantial reliance on medical supply and defense health customers.

Luminex holds four major parent contract vehicles. The largest is an Indefinite Delivery Contract (SPE2DH22D0002) issued by the Defense Logistics Agency with 338 task orders generating $3.9 million in combined potential value—this vehicle anchors most of Luminex's high-volume, low-value delivery orders for diagnostic consumables and verification kits. The GSA Federal Supply Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test Kits carries 37 task orders and $8.6 million across multiple BPA calls to VA, DoD, and USDA customers. The Multiple Award Schedule (MAS) supports 21 task orders for $1.5 million, primarily maintenance and service agreements. The Air Force Blanket Purchase Agreement FA860119AA001 (the 711th HPW vehicle) has generated 19 task orders for $4.3 million. These vehicles enable streamlined procurement of Luminex's reagents and maintenance services across federal health and defense organizations.

Activity has remained stable, with 89 awards in 2022 ramping to 118 in 2024 before moderating to 98 in 2025 and 71 through September 2026. Combined potential value across all 1,363 awards totals $164.5 million, with $76.7 million already obligated (47% execution rate). Only 17 awards with a combined potential value of $1 million face ultimate completion within the next twenty-four months, indicating minimal recompete exposure relative to portfolio size. The source captures a subcontract role on a Department of Homeland Security contract through Battelle National Biodefense Institute for multiple Luminex supplies, and a sub-award from the National Foundation for the Centers for Disease Control & Prevention under a health security partnership grant funded by the American Rescue Plan.

The portfolio clusters heavily in three NAICS categories: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (350 awards); Analytical Laboratory Instrument Manufacturing (250 awards); and In-Vitro Diagnostic Substance Manufacturing (167 awards). PSC coding mirrors this—Hospital Furniture, Equipment, Utensils, and Supplies (339 awards); Laboratory Equipment and Supplies (299 awards); and Maintenance/Repair/Rebuild of Laboratory Equipment (235 awards). Luminex has no named subcontractors in the award history; the company operates as a sole-source or single-source vendor on most contracts, a posture reinforced by sole-source justifications citing compatibility with established Luminex platforms at customer sites. Most awards require no competitive set-aside, reflecting Luminex's established position as the primary supplier of its proprietary diagnostic systems to federal laboratories.

Quick answers

Is Luminex Corp registered in SAM.gov?

Yes. Luminex Corp's SAM.gov registration is active through May 13, 2027.

Which contract vehicles does Luminex Corp hold?

Luminex Corp holds a place on 3 federal contract vehicles, including MAS.

How much has Luminex Corp received in federal contracts?

Federal contracts obligated $2,553,269 to Luminex Corp in fiscal year 2025 and $6,766,987 in fiscal years 2023 through 2027.

How does Luminex Corp rank among federal contractors?

Luminex Corp's parent company, Diasorin S.P.A., ranked #10 in NAICS 325413, #18 in PSC 6550 and #26 in PSC 6632 in FY2025.

What is Luminex Corp's most recent federal award?

Luminex Corp's most recent federal contract award is Magpix maintenance (HT942726PE007), from Defense Health Agency, on September 22, 2026.

On GovTribe

See Luminex Corp's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors